IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders - IGC Pharma, INC.

Press

Releases

May 8, 2020

IGC Announces Proposed Settlement of 3 Derivative Lawsuits & Provides Notice to Shareholders

Related Posts

IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability

January 6, 2026

IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial

January 5, 2026

IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum

December 19, 2025

CEO Update

igc pharma

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

igc pharma

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026